New Partnership Between St. Jude Medical and Mended Little Hearts Benefits Families of Kids with Congenital Heart Defects
27 April 2015 - 10:00PM
Business Wire
Global medical device manufacturer shines a spotlight on
pediatric cardiology, honoring health care providers and
celebrating children who fight the toughest battles
Parents of children living with congenital heart defects often
struggle to find the resources they need to feel a part of their
child’s medical future.
Congenital heart defects (CHDs) are the most common form of
birth defect among American infants, with more than 40,000 babies
born each year in the U.S. with a serious, underlying heart
condition. A new initiative by the non-profit Mended Little Hearts
and St. Jude Medical, Inc., a global medical device manufacturer,
will offer an important new online resource for parents and
caregivers of children undergoing pediatric cardiology
procedures.
The Mended Little Heart Guide will provide accurate and reliable
information and much-needed support and educational resources at a
critical time for families of children affected by CHD. This online
resource will empower parents and caregivers with educational
information in one comprehensive guide, written and reviewed by
medical professionals and edited by parents and caregivers of
children with congenital heart disease.
“We are thrilled to be partnering with St. Jude Medical and
developing a practical resource to help parents cope with and
navigate the CHD diagnosis,” said Jodi Lemacks, national program
director of Mended Little Hearts who is also the mother of a child
living with a heart defect. “The Mended Little Heart Guide will be
made freely available online and easily accessible for parents,
caregivers and hospitals to use virtually anywhere.”
Mended Little Hearts plays a significant role in the lives of
families with children diagnosed with CHDs. Through its support
group meetings, health education to communities, advocacy for
policy and one-on-one visits from parents who have endured the same
journey, the organization provides answers for families learning
their child will receive a life-saving medical device or
procedure.
St. Jude Medical is a market leader in the research, design and
development of electrophysiology and interventional cardiology
solutions for pediatric patients worldwide. The company’s
mechanical heart valves have long been the gold standard for
replacing a failing heart valve and in February St. Jude Medical
announced the launch of the HALO U.S. IDE clinical trial for
pediatric patients in need of mitral valve replacement.
“At St. Jude Medical, we are dedicated to giving children the
big breakthroughs they deserve,” said Dr. Mark Carlson, vice
president of global clinical affairs and chief medical officer at
St. Jude Medical. “Now, we’re partnering with Mended Little Hearts
to promote parent and caregiver education. With efforts like these
we’re bringing our commitment to this critical area of health care
into even sharper focus.”
For more information on the partnership and St. Jude Medical’s
commitment to pediatric cardiology, visit sjm.com/weheartkids.
About Mended Little Hearts
Mended Little Hearts is a program of The Mended Hearts Inc., a
non-profit, volunteer-based organization providing hope, help and
healing to heart patients and their families since 1951. The Mended
Little Hearts program works nationally and in communities to
support children with congenital heart defects and their families.
Learn more at mendedlittlehearts.org.
About St. Jude Medical
St. Jude Medical is a global medical device manufacturer
dedicated to transforming the treatment of some of the world’s most
expensive epidemic diseases. The company does this by developing
cost-effective medical technologies that save and improve lives of
patients around the world. Headquartered in St. Paul, Minn., St.
Jude Medical has four major clinical focus areas that include
cardiac rhythm management, atrial fibrillation, cardiovascular and
neuromodulation. For more information, please visit sjm.com or
follow us on Twitter @SJM_Media.
Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties. Such forward-looking
statements include the expectations, plans and prospects for the
Company, including potential clinical successes, anticipated
regulatory approvals and future product launches, and projected
revenues, margins, earnings and market shares. The statements made
by the Company are based upon management’s current expectations and
are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include
market conditions and other factors beyond the Company’s control
and the risk factors and other cautionary statements described in
the Company’s filings with the SEC, including those described in
the Risk Factors and Cautionary Statements sections of the
Company’s Annual Report on Form 10-K for the fiscal year ended
January 3, 2015. The Company does not intend to update these
statements and undertakes no duty to any person to provide any such
update under any circumstance.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20150427005201/en/
St. Jude MedicalMicki Sievwright,
651-756-4615msievwright@sjm.comorMended Little HeartsJodi Lemacks,
804-419-7028Jodi.Lemacks@mendedlittlehearts.org
SJM (NYSE:STJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Apr 2023 to Apr 2024